Charles S Scott Schumacher, MD
Orthopedic Surgery · Covington
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 15 years
- Louisiana State University School of Medicine in Shreveport, 2011
Offices
2 locations · Lmg LLC · 6 clinicians in this group
Hospitals listed: 197123 · 197168 · 197179 · Avala · Riverside Medical Center · St Tammany Parish Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Schumacher’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A139130 · Cancelled
Licence status: Cancelled · since 2015 · Louisiana State University School of Medicine in New Orleans.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- AvalaCovington, LAAcute Care Hospital · Physician · No emergency departmentPart of LCMC Health System, which runs 11 hospitalsPatients rate it 5 of 5 · 89% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- Riverside Medical CenterFranklinton, LACritical Access Hospital · Government - Hospital District or Authority · Has an emergency departmentNo overall ratingNo measure marked better or worse than the national rate
- St Tammany Parish HospitalCovington, LAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Saint Tammany Health SystemPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.154, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.155, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.531, Oct 2024 – Sep 2025
See every measure and the patient survey for Avala
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.13) · 169 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.41 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 348 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 337 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 329 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.09 (0.6 to 5.57) · 336 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.47 (0.8 to 4.15) · 331 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (0 to 16.36) · 334 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.81 (0.65 to 8.97) · 330 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.76 (0.23 to 3.3) · 123 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.62 (0 to 1.95) · 62 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 40 cases | None | Apr 2023 – Mar 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 36 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 429 cases | No different | Jan 2024 – Dec 2024 |
What patients said (354 patients answered, 43% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 5 |
| Discharge information | 5 |
| Overall hospital rating | 5 |
| Quietness | 5 |
| Recommend hospital | 5 |
| Room was "always" clean | 81% |
| Nurses "always" communicated well | 91% |
| Doctors "always" communicated well | 88% |
| Staff "always" explained | 79% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 84% |
| Doctors "always" listened carefully | 87% |
| Doctors "always" treated them with courtesy and respect | 91% |
| Patients who gave a rating of "9" or "10" (high) | 89% |
| Staff "always" explained new medications | 89% |
| Nurses "always" explained things so they could understand | 89% |
| Nurses "always" listened carefully | 90% |
| Nurses "always" treated them with courtesy and respect | 95% |
| "Always" quiet at night | 82% |
| "YES", patients would definitely recommend the hospital | 89% |
| Staff "always" explained possible side effects | 68% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for Riverside Medical Center
Behind the star rating — Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 47 cases | None | Jul 2024 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.3 (9.8 to 18.1) · 115 cases | No different | Jan 2022 – Dec 2024 |
See every measure and the patient survey for St Tammany Parish Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.154 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.155 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.531 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.89 (0 to 1.89) · 927 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.74 (0.41 to 1.07) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 178.13 (117.96 to 238.3) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 80 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.6 · 117 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.5 · 373 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 296 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 237 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 3,489 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.06 to 0.46) · 4,986 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 5,125 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (1.2 to 5.5) · 1,183 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.39 (0 to 2.97) · 415 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.55 (1.03 to 4.07) · 1,079 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.5 (0 to 13.03) · 412 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.97 (0.19 to 7.74) · 399 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.15) · 196 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.19 (0 to 0.94) · 4,109 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 31 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.501 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.712 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.3 · 306 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 814 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -14 · 152 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -6 · 410 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 16 · 302 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 637 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 35 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.7 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 299 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.3 (10.9 to 18.9) · 448 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 586 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,296 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 5 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 83% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 92% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 79% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 80% |
| Nurses "always" listened carefully | 81% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 68% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 92% |
Original Medicare doctor bills
$319,511
Medicare paid this office $319,511 for 399 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Replacement of knee joint, both sides of knee | 56 | $52,948 | $897 |
| Replacement of thigh bone and hip joint with prosthesis | 31 | $29,105 | $910 |
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 31 | $27,144 | None |
| Return visit (30+ min) | 196 | $23,199 | $82 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 105 | $18,592 | $166 |
See all 23 services
| Replacement of knee joint, both sides of knee | 56 | $52,948 | $897 |
| Replacement of thigh bone and hip joint with prosthesis | 31 | $29,105 | $910 |
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 31 | $27,144 | None |
| Return visit (30+ min) | 196 | $23,199 | $82 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 105 | $18,592 | $166 |
| Destruction of peripheral nerve or branch | 32 | $18,440 | $102 |
| Short return visit (20+ min) | 185 | $17,967 | $58 |
| Long return visit (40+ min) | 58 | $9,327 | $121 |
| X-ray of knee, 1-2 views | 226 | $8,909 | $21 |
| X-ray of both knees while standing | 223 | $8,870 | $25 |
| New patient visit (45+ min) | 73 | $7,319 | $100 |
| Aspiration and/or injection of fluid from large joint | 99 | $7,122 | $47 |
| X-ray of hip, 1 view | 171 | $6,084 | $20 |
| New patient visit (60+ min) | 45 | $6,067 | $135 |
| Ultrasonic guidance for needle placement | 32 | $1,490 | $40 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 17 | $1,441 | $69 |
| Telephone medical discussion with physician, 5-10 minutes | 18 | $748 | $36 |
| X-ray of lower and sacral spine, minimum of 4 views | 14 | $490 | $35 |
| Injection, methylprednisolone acetate, 1 mg | 61 | $433 | None |
| Aspiration and/or injection of fluid from large joint | 16 | $421 | $25 |
| X-ray of joints, multiple | 15 | $420 | $28 |
| X-ray of thigh bone, minimum 2 views | 11 | $264 | $22 |
| Injection, methylprednisolone acetate, 40 mg | 16 | $86 | None |
Procedures Medicare counted
| Hip replacement | 52 | More than 88% of doctors who do this |
| Knee replacement | 89 | More than 91% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | 86 | 67 | 106 | 124 | 192 | 168 |
| Replacement of knee joint, both sides of knee | 46 | 46 | 31 | 44 | 51 | 59 |
| Destruction of peripheral nerve or branch | – | – | – | – | – | 181 |
| Replacement of thigh bone and hip joint with prosthesis | 15 | 12 | 21 | 23 | 25 | 32 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | – | – | – | – | – | 21 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
399 Original Medicare patients in 2024. Average age 74 · Under 65 5% · 85 and older 7% · Women 64% · Also on Medicaid 6% · Health risk score 1.22. Above the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 75% · Coronary heart disease 38% · Depression 28% · Diabetes 27% · Atrial fibrillation 21% · Chronic kidney disease 18% · Cancer 17% · COPD 17% · Heart failure 14% · Stroke 7% · Dementia 5%.
The office billed $2,555,329, Medicare allowed $414,600 and paid $319,511; for 9,417 services of 94 kinds; $31,209 of it was for drugs given in the office and $288,302 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 399 | 9,417 | 74 | 1.22 | $2,555,329 | $319,511 |
| 2023 | 380 | 4,763 | 73 | 1.28 | $1,936,877 | $275,702 |
| 2022 | 300 | 3,182 | 73 | 1.25 | $1,248,373 | $193,865 |
| 2021 | 243 | 2,323 | 72 | 1.34 | $972,513 | $153,668 |
| 2020 | 234 | 1,432 | 71 | 1.29 | $954,268 | $136,231 |
| 2019 | 253 | 1,630 | 73 | 1.42 | $1,050,908 | $162,499 |
| 2018 | 192 | 1,088 | 72 | 1.41 | $873,532 | $104,500 |
| 2017 | 74 | 284 | 73 | 1.22 | $243,069 | $31,209 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Replacement of knee joint, both sides of knee | 49 | $40,874 | $801 |
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 30 | $28,607 | None |
| Replacement of thigh bone and hip joint with prosthesis | 24 | $23,577 | $943 |
| Return visit (30+ min) | 167 | $20,276 | $87 |
| Short return visit (20+ min) | 170 | $16,819 | $62 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 65 | $12,240 | $183 |
| New patient visit (45+ min) | 91 | $10,209 | $112 |
| Long return visit (40+ min) | 63 | $9,610 | $128 |
| Aspiration and/or injection of fluid from large joint | 117 | $9,434 | $49 |
| X-ray of both knees while standing | 190 | $8,900 | $26 |
| X-ray of knee, 1-2 views | 191 | $8,839 | $23 |
| New patient visit (60+ min) | 49 | $7,595 | $155 |
| X-ray of hip, 1 view | 167 | $6,810 | $23 |
| X-ray of joints, multiple | 19 | $614 | $32 |
| Injection, methylprednisolone acetate, 40 mg | 54 | $397 | None |
| Injection, methylprednisolone acetate, 80 mg | 36 | $369 | None |
2022: 18 services
| Replacement of knee joint, both sides of knee | 43 | $28,366 | $645 |
| Replacement of thigh bone and hip joint with prosthesis | 22 | $22,594 | $982 |
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 19 | $18,901 | None |
| Short return visit (20+ min) | 150 | $18,102 | $60 |
| Return visit (30+ min) | 96 | $11,523 | $93 |
| New patient visit (45+ min) | 78 | $8,440 | $108 |
| X-ray of both knees while standing | 153 | $7,990 | $27 |
| X-ray of knee, 1-2 views | 154 | $7,752 | $23 |
| Aspiration and/or injection of fluid from large joint | 79 | $6,229 | $50 |
| X-ray of hip, 1 view | 118 | $4,781 | $22 |
| Long return visit (40+ min) | 23 | $3,437 | $132 |
| New patient visit (60+ min) | 20 | $3,201 | $160 |
| Short return visit | 21 | $857 | $41 |
| X-ray of joints, multiple | 21 | $729 | $35 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $636 | $58 |
| Telephone medical discussion with physician, 5-10 minutes | 11 | $436 | $40 |
| Injection, methylprednisolone acetate, 40 mg | 45 | $279 | None |
| Injection, methylprednisolone acetate, 80 mg | 14 | $150 | None |
2021: 15 services
| Replacement of knee joint, both sides of knee | 30 | $20,518 | $662 |
| Short return visit (20+ min) | 153 | $19,144 | $62 |
| Replacement of thigh bone and hip joint with prosthesis | 21 | $17,824 | $849 |
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 13 | $17,658 | None |
| New patient visit (45+ min) | 79 | $8,481 | $107 |
| Return visit (30+ min) | 66 | $7,582 | $95 |
| X-ray of knee, 1-2 views | 126 | $5,609 | $22 |
| X-ray of both knees while standing | 125 | $5,565 | $25 |
| X-ray of hip, 1 view | 103 | $5,186 | $22 |
| Aspiration and/or injection of fluid from large joint | 71 | $4,917 | $46 |
| Short return visit | 16 | $770 | $41 |
| X-ray of joints, multiple | 12 | $384 | $30 |
| X-ray of lower and sacral spine, minimum of 4 views | 11 | $372 | $34 |
| Injection, methylprednisolone acetate, 40 mg | 43 | $254 | None |
| Injection, methylprednisolone acetate, 80 mg | 17 | $175 | None |
2020: 16 services
| Replacement of knee joint, both sides of knee | 44 | $18,502 | $402 |
| Short return visit (20+ min) | 127 | $12,562 | $50 |
| Replacement of thigh bone and hip joint with prosthesis | 12 | $8,717 | $726 |
| New patient visit (45+ min) | 65 | $7,597 | $117 |
| X-ray of knee, 1-2 views | 94 | $5,116 | $23 |
| X-ray of both knees while standing | 92 | $4,859 | $25 |
| X-ray of hip, 1 view | 87 | $3,567 | $22 |
| Aspiration and/or injection of fluid from large joint | 55 | $2,910 | $43 |
| Return visit (30+ min) | 31 | $2,089 | $65 |
| Initial hospital care with same-day admission and discharge with straightforward or low level of medical decision making, per day at least 45 minutes | 12 | $1,169 | $97 |
| Short return visit | 21 | $768 | $32 |
| X-ray of joints, multiple | 15 | $477 | $32 |
| X-ray of shoulder, minimum of 2 views | 14 | $413 | $24 |
| X-ray of shoulder blade | 14 | $348 | $20 |
| Injection, methylprednisolone acetate, 80 mg | 29 | $348 | None |
| Injection, methylprednisolone acetate, 40 mg | 23 | $149 | None |
2019: 14 services
| Replacement of knee joint, both sides of knee | 46 | $23,377 | $508 |
| Short return visit (20+ min) | 131 | $16,143 | $50 |
| Replacement of thigh bone and hip joint with prosthesis | 14 | $12,227 | $815 |
| New patient visit (45+ min) | 74 | $6,935 | $94 |
| X-ray of knee, 1-2 views | 97 | $4,780 | $21 |
| X-ray of both knees while standing | 95 | $4,410 | $24 |
| X-ray of hip, 1 view | 86 | $3,944 | $21 |
| Aspiration and/or injection of fluid from large joint | 66 | $3,545 | $41 |
| Return visit (30+ min) | 35 | $2,795 | $76 |
| Initial hospital care with same-day admission and discharge with straightforward or low level of medical decision making, per day at least 45 minutes | 19 | $2,005 | $106 |
| X-ray of joints, multiple | 29 | $841 | $28 |
| X-ray of thigh bone, minimum 2 views | 14 | $815 | $23 |
| X-ray of lower and sacral spine, minimum of 4 views | 12 | $461 | $35 |
| Injection, methylprednisolone acetate, 40 mg | 55 | $344 | None |
2018: 13 services
| Replacement of thigh bone and hip joint with prosthesis | 21 | $10,705 | $510 |
| Short return visit (20+ min) | 97 | $9,551 | $53 |
| New patient visit (45+ min) | 68 | $7,511 | $110 |
| Replacement of knee joint, both sides of knee | 23 | $5,898 | $246 |
| X-ray of hip, 1 view | 57 | $2,850 | $21 |
| Aspiration and/or injection of fluid from large joint | 43 | $2,550 | $46 |
| Return visit (30+ min) | 29 | $2,327 | $71 |
| X-ray of knee, 1-2 views | 54 | $2,282 | $22 |
| X-ray of both knees while standing | 53 | $2,034 | $25 |
| X-ray of joints, multiple | 20 | $576 | $27 |
| X-ray of shoulder blade | 13 | $356 | $22 |
| X-ray of shoulder, minimum of 2 views | 13 | $344 | $22 |
| Injection, methylprednisolone acetate, 40 mg | 31 | $197 | None |
2017: 6 services
| Replacement of thigh bone and hip joint with prosthesis | 11 | $5,908 | $537 |
| New patient visit (45+ min) | 17 | $2,004 | $118 |
| Return visit (30+ min) | 12 | $1,057 | $81 |
| Short return visit (20+ min) | 17 | $992 | $55 |
| X-ray of hip, 1 view | 13 | $348 | $22 |
| X-ray of hip, 2-3 views | 11 | $123 | $9 |
Medicaid work
$0 in 2024
Medicaid paid $0 for 147 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease | 147 | $0 |
| 2024 | 147 | 1 | 18 | $0 |
| 2023 | 237 | 3 | 21 | $18 |
| 2022 | 72 | 1 | 15 | $0 |
| 2021 | 137 | 2 | 19 | $71 |
| 2020 | 17 | 1 | 14 | $15 |
| 2019 | 44 | 1 | 13 | $108 |
See the largest Medicaid services in earlier years
2023
| X-ray of knee, anteroposterior and lateral views | 18 | $18 |
| Radiologic examination, knee; both knees, standing, anteroposterior | 13 | $0 |
| Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease | 206 | $0 |
2022
| Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease | 72 | $0 |
2021
| Short return visit (20+ min) | 30 | $71 |
| Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease | 107 | $0 |
2020
| Short return visit (20+ min) | 17 | $15 |
2019
| Short return visit (20+ min) | 44 | $108 |
Drugs they prescribed that Part D paid
$15,978
Pharmacies billed $15,978 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 36% of their Part D prescriptions (636 of 1,787) in 2024. Above the middle of the specialty; the typical orthopedic surgery clinician is at 31%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
1,785 generic and fewer than 11 brand-name prescriptions · $15,978 in drug cost · 214 antibiotic prescriptions to 124 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Enoxaparin | 61 | $4,814 | $79 |
| Oxycodone | 270 | $1,697 | $6 |
| Ondansetron | 264 | $1,250 | $5 |
| Tramadol | 340 | $1,083 | $3 |
| Mupirocin | 107 | $740 | $7 |
See all 23 drugs
| Enoxaparin | 61 | $4,814 | $79 |
| Oxycodone | 270 | $1,697 | $6 |
| Ondansetron | 264 | $1,250 | $5 |
| Tramadol | 340 | $1,083 | $3 |
| Mupirocin | 107 | $740 | $7 |
| Cefadroxil | 51 | $559 | $11 |
| Meloxicam | 151 | $521 | $3 |
| Diclofenac | 30 | $403 | $13 |
| Methylprednisolone | 49 | $311 | $6 |
| Ibuprofen | 27 | $286 | $11 |
| Chlorhexidine Gluconate | 66 | $244 | $4 |
| Gabapentin | 47 | $238 | $5 |
| Doxycycline Hyclate | 16 | $166 | $10 |
| Hydrocodone-Acetaminophen | 23 | $163 | $7 |
| Pregabalin | 17 | $146 | $9 |
| Celecoxib | 18 | $121 | $7 |
| Amoxicillin | 97 | $110 | $1 |
| Cyclobenzaprine | 29 | $104 | $4 |
| Famotidine | 12 | $69 | $6 |
| Cephalexin | 13 | $46 | $4 |
| Promethazine | 12 | $45 | $4 |
| Clindamycin | 12 | $32 | $3 |
| Diazepam | 11 | $11 | $1 |
Year by year
| 2024 | 1,787 | 457 | 36% (636) | None | $15,978 |
| 2023 | 1,596 | 381 | 39% (616) | None | $16,772 |
| 2022 | 1,434 | 309 | 44% (628) | 1% | $22,635 |
| 2021 | 1,301 | 276 | 37% (483) | 1% | $26,152 |
| 2020 | 1,175 | 239 | 32% (374) | 2% | $19,364 |
| 2019 | 754 | 182 | 33% (248) | 6% | $19,081 |
| 2018 | 357 | 93 | 36% (127) | 14% | $37,561 |
| 2017 | 52 | 24 | 37% (19) | None | $792 |
| 2016 | 40 | 22 | 40% (16) | None | $1,739 |
| 2015 | 36 | 24 | 61% (22) | None | $1,793 |
| 2014 | 41 | 27 | 56% (23) | None | $2,851 |
| 2013 | 13 | None | None | None | $1,162 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Enoxaparin | 43 | $3,576 | $83 |
| Diclofenac | 66 | $1,564 | $24 |
| Oxycodone | 244 | $1,527 | $6 |
| Tramadol | 340 | $1,133 | $3 |
| Ondansetron | 156 | $772 | $5 |
| Doxycycline Hyclate | 43 | $720 | $17 |
| Mupirocin | 89 | $611 | $7 |
| Methylprednisolone | 40 | $299 | $7 |
| Meloxicam | 98 | $282 | $3 |
| Gabapentin | 75 | $274 | $4 |
| Pregabalin | 20 | $258 | $13 |
| Hydrocodone-Acetaminophen | 28 | $229 | $8 |
| Celecoxib | 22 | $189 | $9 |
| Chlorhexidine Gluconate | 46 | $189 | $4 |
| Cyclobenzaprine | 28 | $132 | $5 |
| Ibuprofen | 24 | $127 | $5 |
| Famotidine | 14 | $107 | $8 |
| Amoxicillin | 92 | $103 | $1 |
| Cephalexin | 19 | $58 | $3 |
| Tizanidine | 17 | $35 | $2 |
2022: 21 drugs
| Eliquis | 13 | $6,793 | $523 |
| Enoxaparin | 41 | $4,130 | $101 |
| Oxycodone | 247 | $2,043 | $8 |
| Ondansetron | 168 | $1,685 | $10 |
| Tramadol | 326 | $1,412 | $4 |
| Doxycycline Hyclate | 48 | $804 | $17 |
| Diclofenac | 46 | $801 | $17 |
| Pregabalin | 59 | $799 | $14 |
| Gabapentin | 67 | $639 | $10 |
| Mupirocin | 61 | $586 | $10 |
| Hydrocodone-Acetaminophen | 47 | $419 | $9 |
| Amoxicillin-Clavulanate Potass | 18 | $263 | $15 |
| Chlorhexidine Gluconate | 31 | $197 | $6 |
| Ibuprofen | 19 | $132 | $7 |
| Cyclobenzaprine | 22 | $122 | $6 |
| Amoxicillin | 48 | $109 | $2 |
| Methylprednisolone | 14 | $103 | $7 |
| Meloxicam | 30 | $88 | $3 |
| Cephalexin | 24 | $75 | $3 |
| Tizanidine | 13 | $67 | $5 |
| Diazepam | 11 | $25 | $2 |
2021: 19 drugs
| Enoxaparin | 25 | $2,324 | $93 |
| Pregabalin | 69 | $2,034 | $29 |
| Diclofenac | 87 | $1,773 | $20 |
| Oxycodone | 196 | $1,646 | $8 |
| Tramadol | 236 | $1,003 | $4 |
| Ondansetron | 133 | $947 | $7 |
| Gabapentin | 80 | $656 | $8 |
| Doxycycline Hyclate | 44 | $596 | $14 |
| Hydrocodone-Acetaminophen | 46 | $498 | $11 |
| Amoxicillin-Clavulanate Potass | 20 | $305 | $15 |
| Methylprednisolone | 36 | $277 | $8 |
| Mupirocin | 32 | $195 | $6 |
| Cyclobenzaprine | 29 | $187 | $6 |
| Chlorhexidine Gluconate | 30 | $146 | $5 |
| Tizanidine | 24 | $104 | $4 |
| Meloxicam | 26 | $70 | $3 |
| Cephalexin | 24 | $57 | $2 |
| Amoxicillin | 25 | $52 | $2 |
| Ciprofloxacin | 14 | $42 | $3 |
2020: 20 drugs
| Diclofenac | 157 | $3,880 | $25 |
| Enoxaparin | 36 | $3,127 | $87 |
| Oxycodone | 152 | $1,649 | $11 |
| Doxycycline Hyclate | 51 | $1,253 | $25 |
| Ondansetron | 108 | $1,184 | $11 |
| Tramadol | 188 | $860 | $5 |
| Gabapentin | 67 | $749 | $11 |
| Pregabalin | 17 | $548 | $32 |
| Mupirocin | 53 | $427 | $8 |
| Chlorhexidine Gluconate | 52 | $286 | $5 |
| Hydrocodone-Acetaminophen | 32 | $284 | $9 |
| Amoxicillin-Clavulanate Potass | 13 | $207 | $16 |
| Methylprednisolone | 22 | $193 | $9 |
| Meloxicam | 42 | $173 | $4 |
| Cyclobenzaprine | 29 | $172 | $6 |
| Famotidine | 12 | $125 | $10 |
| Ibuprofen | 11 | $98 | $9 |
| Amoxicillin | 14 | $73 | $5 |
| Tizanidine | 11 | $71 | $6 |
| Sulfamethoxazole-Trimethoprim | 14 | $56 | $4 |
2019: 15 drugs
| Diclofenac | 123 | $3,939 | $32 |
| Enoxaparin | 22 | $2,966 | $135 |
| Doxycycline Hyclate | 40 | $1,117 | $28 |
| Voltaren | 18 | $999 | $55 |
| Oxycodone | 94 | $977 | $10 |
| Gabapentin | 51 | $524 | $10 |
| Tramadol | 99 | $478 | $5 |
| Ondansetron | 52 | $456 | $9 |
| Mupirocin | 42 | $410 | $10 |
| Hydrocodone-Acetaminophen | 40 | $373 | $9 |
| Amoxicillin-Clavulanate Potass | 12 | $196 | $16 |
| Chlorhexidine Gluconate | 31 | $170 | $5 |
| Ibuprofen | 11 | $116 | $11 |
| Amoxicillin | 13 | $61 | $5 |
| Meloxicam | 17 | $57 | $3 |
2018: 10 drugs
| Voltaren | 21 | $1,262 | $60 |
| Oxycodone | 72 | $1,082 | $15 |
| Doxycycline Hyclate | 15 | $693 | $46 |
| Diclofenac | 11 | $384 | $35 |
| Tramadol | 36 | $225 | $6 |
| Mupirocin | 22 | $205 | $9 |
| Hydrocodone-Acetaminophen | 14 | $140 | $10 |
| Chlorhexidine Gluconate | 21 | $116 | $6 |
| Gabapentin | 13 | $91 | $7 |
| Diazepam | 18 | $82 | $5 |
2015: 1 drug
| Oxycodone | 13 | $278 | $21 |
2014: 1 drug
| Oxycodone | 13 | $250 | $19 |
Money from drug and device companies
$3,105 in 2025
| 2025 | 7 | 29 | None | $3,105 |
| 2024 | 3 | 10 | None | $474 |
| 2023 | 7 | 27 | None | $4,117 |
| 2022 | 6 | 17 | None | $749 |
| 2021 | 12 | 38 | None | $1,657 |
| 2020 | 4 | 23 | None | $822 |
| 2019 | 6 | 54 | None | $2,835 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Mako | $2,791 | 23 payments
|
| Davol | Channel Drain | $190 | 1 payment
|
| Alon Medical Technology | None | $34 | 1 payment
|
| Acera Surgical | Restrata Wound Matrix | $32 | 1 payment
|
| Biocomposites | Stimulan | $29 | 1 payment
|
| Vertex Pharmaceuticals | Journavx | $15 | 1 payment
|
See all 29 published payments
| Stryker | Meals · 2025-12-22 | Mako | $18 |
| Alon Medical Technology | Meals · 2025-11-13 | None | $34 |
| Stryker | Meals · 2025-11-11 | Mako | $8 |
| Acera Surgical | Meals · 2025-11-06 | Restrata Wound Matrix | $32 |
| Stryker | Meals · 2025-10-24 | Mako | $40 |
| Stryker | Meals · 2025-09-17 | Mako | $36 |
| Stryker | Meals · 2025-09-12 | Mako | $15 |
| Stryker | Meals · 2025-09-12 | Mako | $140 |
| Stryker | Meals · 2025-09-12 | Mako | $50 |
| Stryker | Meals · 2025-09-12 | Mako | $20 |
| Amgen | Meals · 2025-09-04 | Evenity | $14 |
| Davol | Meals · 2025-07-17 | Channel Drain | $190 |
| Stryker | Meals · 2025-07-15 | Mako | $136 |
| Stryker | Meals · 2025-07-15 | Mako | $6 |
| Stryker | Travel · 2025-06-12 | Mako | $350 |
| Stryker | Meals · 2025-06-12 | Mako | $104 |
| Stryker | Meals · 2025-05-22 | Mako | $44 |
| Vertex Pharmaceuticals | Meals · 2025-02-25 | Journavx | $15 |
| Biocomposites | Meals · 2025-02-20 | Stimulan | $29 |
| Stryker | Travel · 2025-02-04 | Mako | $378 |
| Stryker | Travel · 2025-02-03 | Mako | $372 |
| Stryker | Travel · 2025-02-01 | Mako | $217 |
| Stryker | Meals · 2025-01-31 | Mako | $24 |
| Stryker | Travel · 2025-01-31 | Mako | $67 |
| Stryker | Meals · 2025-01-30 | Mako | $21 |
| Stryker | Meals · 2025-01-30 | Mako | $32 |
| Stryker | Meals · 2025-01-30 | Mako | $119 |
| Stryker | Travel · 2025-01-22 | Mako | $138 |
| Stryker | Travel · 2025-01-07 | Mako | $455 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $474
| Stryker | Mako | $431 | 8 payments
|
| Innovation Technologies | Irrisept | $25 | 1 payment
|
| Bioventus | Exogen Ultrasound Bone Healing System | $17 | 1 payment
|
2023: $4,117
| Stryker | Mako | $2,458 | 16 payments
|
| American Orthodontics | Empower-Metal | $1,411 | 3 payments
|
| Novus Surgical Consultants | None | $125 | 2 payments
|
| Biocomposites | Stimulan | $53 | 2 payments
|
| AbbVie | Dalvance | $32 | 2 payments
|
| Davol | None | $23 | 1 payment
|
| Amgen | Evenity | $16 | 1 payment
|
2022: $749
| Stryker | Mako | $653 | 11 payments
|
| Kowa Pharmaceuticals America | Seglentis | $37 | 2 payments
|
| Fidia Pharma USA | Hymovis | $18 | 1 payment
|
| Horizon Therapeutics plc | Pennsaid | $15 | 1 payment
|
| Innovation Technologies | Irrisept | $14 | 1 payment
|
| Pacira Pharmaceuticals | Iovera | $13 | 1 payment
|
2021: $1,657
| Stryker | Mako | $1,123 | 15 payments
|
| DePuy Synthes Sales | Fibulink | $221 | 2 payments
|
| Horizon Therapeutics plc | Pennsaid | $114 | 9 payments
|
| AbbVie | Dalvance | $40 | 3 payments
|
| Amgen | Evenity | $29 | 2 payments
|
| Fidia Pharma USA | Hymovis | $26 | 1 payment
|
| Pacira Therapeutics | Zilretta | $22 | 1 payment
|
| Ethicon US | Stratafix | $21 | 1 payment
|
| Tissuetech | Neox | $20 | 1 payment
|
| Ermi | None | $17 | 1 payment
|
| Bioventus | Exogen Ultrasound Bone Healing System | $14 | 1 payment
|
| Boston Scientific | General - Pain Management | $12 | 1 payment
|
2020: $822
| Stryker | Mako | $719 | 18 payments
|
| Ethicon US | Stratafix | $46 | 2 payments
|
| Flexion Therapeutics | Zilretta | $41 | 2 payments
|
| Horizon Therapeutics plc | Duexis | $15 | 1 payment
|
2019: $2,835
| Stryker | Mako | $2,494 | 32 payments
|
| DePuy Synthes Sales | Bme Nitinol Continuous Compression Implants | $169 | 2 payments
|
| Horizon Therapeutics plc | Pennsaid | $132 | 17 payments
|
| Nevro | Senza Spinal Cord Stimulation System | $16 | 1 payment
|
| Avanos Medical | On-Q* Pump and Accessories | $12 | 1 payment
|
| Integra LifeSciences | Salto Talaris Total Ankle Prosthesis | $11 | 1 payment
|
Checkups this office reported
11 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 34.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 0%That's few of the people this applied to. | 915 |
| Checked for fall riskOlder patients screened for fall risk | 0%That's few of the people this applied to. | 806 |
| Closing the Referral Loop: Receipt of Specialist ReportAs Medicare defines this measure | 49% | 697 |
| Daily function assessedPatients whose ability to manage daily activities was assessed | 0%That's few of the people this applied to. | 81 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 100%That's most of the people this applied to. Worse on this measure. | 69 |
| Medications listed in the chartVisits where the current medication list was documented | 96%That's most of the people this applied to. | 2,917 |
| Risk-standardized complication rate (RSCR) following elective primary total hip arthroplasty (THA) and/or total knee arthroplasty (TKA) for Merit-based Incentive Payment System (MIPS)As Medicare defines this measure | 0% | None |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 865 |
See the other 3 measures
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 0% | 451 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 70%That's more than half. | 70 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 22%That's few of the people this applied to. | 1,436 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Implementation of medication management practice improvements
- Improved the patient portal
- Uses standard treatment protocols
Professional record
- NPI
- 1447544465
- Licence
- CA A139130, LA 305240, MA L-247927California A139130: Cancelled
- Trained
- Louisiana State University School of Medicine in Shreveport, 2011 · 15 years ago
- Group
- Lmg LLC
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- LA 2449010
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 19343 Sunshine Ave, Covington, LA, 70433
- NPI first listed
- 2011-06-07
- NPI last updated
- 2019-08-27
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305